logo
logo

Candid Therapeutics raised $370M in a Series A funding round to develop antibody drugs for inflammatory diseases.

Candid Therapeutics raised $370M in a Series A funding round to develop antibody drugs for inflammatory diseases.

09/09/24, 1:34 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan diego
Money raised
$370 million
Industry
therapeutics
biotechnology
health care
Round Type
series a
Candid Therapeutics, a new biotech company, secured over $370 million in funding to develop treatments for autoimmune diseases. The funding will allow them to operate for several years and explore opportunities for an initial public offering.

Company Info

Company
Candid Therapeutics
Location
san diego, california, united states
Additional Info
Clinical stage biotechnology company dedicated to advancing the treatment of a range of immunological conditions

Related People